Bank of Montreal’s DexCom DXCM Stock Holding History

Bank of Montreal’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$1.24M	–	3972
2023 Q4	$1.24M	Buy	+10,000	New	+$1.02M	﹤0.01%	1933

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of Montreal's DXCM Position: Q2 2026 in Review

Bank of Montreal increased its DexCom (DXCM) stake by 33% in Q2 2026, buying an estimated $7.06M and bringing the position to 426,466 shares worth $28.7M. The position accounts for 0.01% of the portfolio, ranked #781.

Bank of Montreal first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $157M in Q4 2023. 727 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Bank of Montreal held 426,466 shares of DexCom worth $28.7M as of Q2 2026.
Bank of Montreal bought 105,956 DexCom shares in Q2 2026, an estimated $7.06M.
DexCom made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #781 holding.
Bank of Montreal first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
Bank of Montreal's DexCom position peaked at $157M in Q4 2023.
727 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.